Remedium Capital Partners, LLC: 13F holdings
CIK 21045012026Q2
| Positions | 6 |
|---|---|
| Reported value | $451.6m |
| Filed | 2026-08-07 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| Oruka Therapeutics Inc | 1,565,661 | $149.0m | 33.0% |
| SYRE Spyre Therapeutics Inc | 1,464,169 | $130.0m | 28.8% |
| Apogee Therapeutics Inc | 586,691 | $77.9m | 17.2% |
| Damora Therapeutics Inc | 2,045,473 | $53.2m | 11.8% |
| Jade Biosciences Inc | 1,577,750 | $35.1m | 7.8% |
| Crescent Biopharma Inc | 361,250 | $6.5m | 1.4% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2104501")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.